Inotiv, Inc. (NOTV)

NCM – Цена в реальном времени. Валюта: USD

0.25

-0.05 (-15.91%)

При закрытии: May 12, 2026, 4:00 PM EDT

0.25

+0.00 (1.26%)

До открытия: May 13, 2026, 8:24 AM EDT

13.02.2026

Inotiv Provides Notice Regarding Cybersecurity Incident

WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, is providing public notice regarding its cybersecurity incident that it became aware of on August 8, 2025.

09.02.2026

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

09.02.2026

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

WEST LAFAYETTE, Ind., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q1 FY 2026”) ended December 31, 2025.

04.02.2026

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

WEST LAFAYETTE, Ind., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2026 first quarter ended December 31, 2025, on Monday, February 9, 2026, before the stock market opens. The Company will host a conference call that same day at 8:30 a.m. Eastern Time to discuss the results.

13.01.2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

WEST LAFAYETTE, Ind., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced a strategic initiative to leverage LifeNet Health's proprietary TruVivo® within its Discovery and Translational Sciences business.

11.12.2025

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, and VUGENE, a multi-omics data analysis company providing advanced artificial intelligence (AI) and machine learning (ML) solutions for biomedical research, today announced a strategic collaboration designed to accelerate AI-assisted drug discovery and enhance data-driven insights across the drug development continuum.

04.12.2025

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

There is no data to display

Пресс-релизы

13.02.2026

Inotiv Provides Notice Regarding Cybersecurity Incident

09.02.2026

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

13.01.2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

11.12.2025

Inotiv, Inc. (NOTV)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inotiv, Inc. (NOTV)

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Search stocks

Inotiv, Inc. (NOTV)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inotiv, Inc. (NOTV)

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv, Inc. (NOTV) Q1 2026 Earnings Call Transcript

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv, Inc. to Report Fiscal 2026 First Quarter Financial Results and Host Conference Call on Monday, February 9, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities

Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Inotiv Provides Notice Regarding Cybersecurity Incident

Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities